
Development of Active Pharmaceutical Ingredients for Clinical Development; Synthesis of a Gamma Secretase Modulator & Commercial Route Development of Glasdegib, a SMO Inhibitor
題 目: Development of Active Pharmaceutical Ingredients for Clinical Development;
Synthesis of a Gamma Secretase Modulator & Commercial Route Development of
Glasdegib, a SMO Inhibitor
報(bào)告人: Dr. Stéphane Caron
Pfizer Worldwide Research & Development
主持人: 胡金波 研究員
時(shí) 間: 09月12日(周四)上午10:00
地 點(diǎn): 君謀樓二樓,第一會(huì)議室
歡迎聽講!
附件下載:

